Paul Tudor Jones's MDLN Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 384,695 shares of Medline Inc. (MDLN) worth $15.17 M, representing 0.02% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in MDLN for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 384,695 shares. Largest reduction occurred in Q1 2026, reducing 464,454 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Medline (MDLN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medline (MDLN) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +384,695 | New Buy | 384,695 | $39.44 |
| Q1 2026 | -464,454 | Sold Out | 0 | $0.00 |
| Q4 2025 | +464,454 | New Buy | 464,454 | $42.00 |
Paul Tudor Jones's Medline Investment FAQs
Paul Tudor Jones first purchased Medline Inc. (MDLN) in Q4 2025, acquiring 464,454 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Medline Inc. (MDLN) for 3 quarters since Q4 2025.
Paul Tudor Jones's largest addition to Medline Inc. (MDLN) was in Q4 2025, adding 464,454 shares worth $19.51 M.
According to the latest 13F filing for Q2 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 384,695 shares of Medline Inc. (MDLN), valued at approximately $15.17 M.
As of the Q2 2026 filing, Medline Inc. (MDLN) represents approximately 0.02% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Medline Inc. (MDLN) was 464,454 shares, as reported at the end of Q4 2025.